Published in Front Microbiol on September 24, 2015
Human parvovirus 4 'PARV4' remains elusive despite a decade of study. F1000Res (2017) 0.77
Co-infections and Pathogenesis of KSHV-Associated Malignancies. Front Microbiol (2016) 0.76
Role of HLA Adaptation in HIV Evolution. Front Immunol (2016) 0.76
Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen. J Virus Erad (2016) 0.76
Elevated cytomegalovirus IgG antibody levels are associated with HIV-1 disease progression and immune activation. AIDS (2017) 0.75
PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort. Wellcome Open Res (2017) 0.75
Cytomegalovirus Infection May Contribute to the Reduced Immune Function, Growth, Development, and Health of HIV-Exposed, Uninfected African Children. Front Immunol (2016) 0.75
Immune Reconstitution Inflammatory Syndrome in HIV infection: taking the bad with the good. Oral Dis (2016) 0.75
Tissue reservoirs of antiviral T cell immunity in persistent human CMV infection. J Exp Med (2017) 0.75
Replication of CMV in the gut of HIV-infected individuals and epithelial barrier dysfunction. PLoS Pathog (2017) 0.75
Cytomegalovirus and paediatric HIV infection. J Virus Erad (2016) 0.75
Barriers to HIV remission research in low- and middle-income countries. J Int AIDS Soc (2017) 0.75
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A (1989) 11.76
Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med (2009) 5.47
Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc Natl Acad Sci U S A (1987) 3.82
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol (2010) 3.52
Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science (1997) 3.36
Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev (2009) 2.75
Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet (2004) 2.54
Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (1999) 2.51
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet (2011) 2.50
Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis (2004) 2.29
The "silent" global burden of congenital cytomegalovirus. Clin Microbiol Rev (2013) 2.28
Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis. Transpl Infect Dis (2015) 2.00
Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J Infect Dis (1995) 1.92
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. J Infect Dis (2014) 1.91
Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J Infect Dis (1989) 1.89
HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature (1990) 1.52
Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis (2010) 1.40
Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol (2005) 1.33
Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS One (2007) 1.33
Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360). Clin Infect Dis (2003) 1.27
Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India. Pediatr Infect Dis J (2008) 1.26
Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol (2007) 1.26
Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression. J Immunol (1989) 1.24
Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies. J Acquir Immune Defic Syndr (2005) 1.19
Viral coinfections among African children infected with human immunodeficiency virus type 1. Clin Infect Dis (2003) 1.18
CMV as a cofactor enhancing progression of AIDS. J Clin Virol (2006) 1.16
Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism. J Clin Invest (1992) 1.12
High rates of congenital cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in sub-Saharan Africa. Clin Infect Dis (2013) 1.10
The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants. AIDS (2009) 1.09
Differences between naive and memory T cell phenotype in Malawian and UK adolescents: a role for Cytomegalovirus? BMC Infect Dis (2008) 1.05
Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: a longitudinal cohort study in Qinba mountain area, China. J Clin Virol (2007) 1.02
Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants. PLoS One (2008) 1.02
Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int J Infect Dis (2014) 1.00
Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa. PLoS One (2011) 0.97
Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa. Clin Infect Dis (2014) 0.97
Cytomegalovirus infection induces T-cell differentiation without impairing antigen-specific responses in Gambian infants. Immunology (2008) 0.95
Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J Med Virol (2009) 0.93
Cytomegalovirus upregulates expression of CCR5 in central memory cord blood mononuclear cells, which may facilitate in utero HIV type 1 transmission. J Infect Dis (2014) 0.91
Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women. PLoS One (2014) 0.90
Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007). J Acquir Immune Defic Syndr (2009) 0.90
The role of co-infections in mother-to-child transmission of HIV. Curr HIV Res (2013) 0.90
Congenital cytomegalovirus infection in Israel: screening in different subpopulations. Isr Med Assoc J (2005) 0.87
CD4(+) T cell responses to cytomegalovirus in early life: a prospective birth cohort study. J Infect Dis (2008) 0.87
High seroprevalence of human herpesviruses in HIV-infected individuals attending primary healthcare facilities in rural South Africa. PLoS One (2014) 0.87
Cytomegalovirus infection and progression to AIDS. Lancet (1989) 0.87
Congenital and postnatal CMV and EBV acquisition in HIV-infected Zimbabwean infants. PLoS One (2014) 0.86
Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease. Curr Opin Virol (2014) 0.86
CD95 (APO-1/Fas) expression on naive CD4(+) T cells increases with disease progression in HIV-infected children and adolescents: effect of highly active antiretroviral therapy (HAART). Pediatr Res (2001) 0.86
Prevalence and risk factors for betaherpesvirus DNAemia in children >3 weeks and <2 years of age admitted to a large referral hospital in sub-Saharan Africa. Clin Infect Dis (2014) 0.86
Cytomegalovirus, and possibly Epstein-Barr virus, shedding in breast milk is associated with HIV-1 transmission by breastfeeding. AIDS (2015) 0.85
Acute cytomegalovirus infection is associated with increased frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infants. J Virol (2012) 0.85
Cytomegalovirus viraemia in HIV exposed and infected infants: prevalence and clinical utility for diagnosing CMV pneumonia. J Clin Virol (2013) 0.83
CMV pneumonia in HIV-infected ventilated infants. Pediatr Pulmonol (2010) 0.83
[Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy]. Enferm Infecc Microbiol Clin (2004) 0.81
Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania. Int J Infect Dis (2012) 0.81
HIV-1 DNA in fibroblast cultures infected with urine from HIV-seropositive cytomegalovirus (CMV) excretors. Arch Virol (1995) 0.81
Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients. Clin Exp Immunol (1998) 0.81
Cytomegalovirus viral load kinetics in patients with HIV/AIDS admitted to a medical intensive care unit: a case for pre-emptive therapy. PLoS One (2014) 0.80
Immune reconstitution in HIV-1-infected individuals treated with potent antiretroviral therapy. J Investig Dermatol Symp Proc (2001) 0.80
Physical function impairment of older, HIV-infected adults is associated with cytomegalovirus immunoglobulin response. AIDS Res Hum Retroviruses (2015) 0.79
Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation. Haematologica (2014) 0.79
Effect of demographic variables on cytomegalovirus antibody seropositivity among prospective blood donors in Jos, Nigeria. Niger Postgrad Med J (2009) 0.79
Seminal Shedding of CMV and HIV Transmission among Men Who Have Sex with Men. Int J Environ Res Public Health (2015) 0.78
Restoration of CD4+ Responses to Copathogens in HIV-Infected Individuals on Antiretroviral Therapy Is Dependent on T Cell Memory Phenotype. J Immunol (2015) 0.77
Human cytomegalovirus infection among patients living with AIDS in a tertiary level hospital in India. J Int Assoc Physicians AIDS Care (Chic) (2010) 0.76
Pre-transplant thymic function is associated with the risk of cytomegalovirus disease after solid organ transplantation. Clin Microbiol Infect (2015) 0.76
Restimulating interest in cytomegalovirus as a cofactor for HIV infection. J Infect Dis (2014) 0.76